HIMSS TV is your Insider’s Guide to everything HIMSS. We are the world’s first online broadcasting network, focused on global innovation and how information and technology are driving change in healthcare.
  Home
Project IMPACT works to address health inequities and racial bias in medicine
AI/ML

Project IMPACT works to address health inequities and racial bias in medicine

8:27

Bias in dermatology toward white skin can result in missed diagnoses for people of color, say VisualDx physicians.

Read More
Read Less

AI/ML - Similar Videos View more in AI/ML

4:40

AION Labs to explore quantum tech

Mati Gill, AION Labs CEO, provides an update on the company’s nine AI-enabled drug discovery portfolio companies, how the organizations are making an impact in life sciences and what’s next for AION, including exploring quantum technologies.

AION Labs to explore quantum tech
Mati Gill, AION Labs CEO, provides an update on the company’s nine AI-enabled drug discovery portfolio companies, how the organizations are making an impact in life sciences and what’s next for AION, including exploring quantum technologies.
4:40
9:56

CIO Spotlight: Artesia General Hospital's Eric Jimenez

The chief information officer of the 25-bed New Mexico nonprofit discusses plan for some new clinical automation tools. He also describes how he's using AI to help with network defense, and how that's enabling gains in other areas.

CIO Spotlight: Artesia General Hospital's Eric Jimenez
The chief information officer of the 25-bed New Mexico nonprofit discusses plan for some new clinical automation tools. He also describes how he's using AI to help with network defense, and how that's enabling gains in other areas.
9:56
6:41

The need to move AI regulation faster

The U.S. Food and Drug Administration's validation requirements process for drug development is a good model for healthcare artificial intelligence governance, explains Michael Abrams, managing partner at Numerof & Associates.

The need to move AI regulation faster
The U.S. Food and Drug Administration's validation requirements process for drug development is a good model for healthcare artificial intelligence governance, explains Michael Abrams, managing partner at Numerof & Associates.
6:41